Category Health/Medical

New Biomarker of Brain Inflammation in early-stage Alzheimer’s disease

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's Disease and associate with neuronal injury markers

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer’s Disease and associate with neuronal injury markers

This secreted marker molecule, which can be measured from CSF taps, may provide clinicians with a rapidly detectable biomarker for the transition from preclinical Alzheimer’s disease to cognitive impairment and progression to full dementia. Such is the conclusion of a multi-center study on a large group of human patients, published online in EMBO Molecular Medicine.

Alzheimer’s disease, an increasing problem in today’s aging populations, is characterized by amyloid peptide plaques and tau protein aggregates in nerve cells...

Read More

New kind of Stem Cell discovered that could lead to advances in regenerative medicine

OSKM-Induced XEN Cells Arise during Reprogramming

OSKM-Induced XEN Cells Arise during Reprogramming

The stem cell discovery could also offer new ways to study birth defects and other reproductive problems. Tony Parenti, MSU cell and molecular biology graduate student, unearthed the new cells – induced XEN cells, or iXEN – in a cellular trash pile, of sorts. “Other scientists may have seen these cells before, but they were considered to be defective, or cancer-like,” said Parenti. “Rather than ignore these cells that have been mislabeled as waste byproducts, we found gold in the garbage.”

A great deal of stem cell research focuses on new ways to make and use pluripotent stem cells. Pluripotent stem cells can be created by reactivating embryonic genes to “reprogram” mature adult cells...

Read More

Monkeys drive Wheelchairs using only their Thoughts

A computer in the lab of Miguel Nicolelis, M.D., Ph.D., monitors brain signals from a rhesus macaque. Nicolelis and Duke researchers record signals from hundreds of neurons in two regions of the monkeys' brains that are involved in movement and sensation. As the animals think about moving toward their goal -- in this case, a bowl containing fresh grapes -- computers translate their brain activity into real-time operation of a wheelchair. Credit: Shawn Rocco/ Duke Health

A computer in the lab of Miguel Nicolelis, M.D., Ph.D., monitors brain signals from a rhesus macaque. Nicolelis and Duke researchers record signals from hundreds of neurons in two regions of the monkeys’ brains that are involved in movement and sensation. As the animals think about moving toward their goal — in this case, a bowl containing fresh grapes — computers translate their brain activity into real-time operation of a wheelchair. Credit: Shawn Rocco/ Duke Health

Neuroscientists have developed a brain-machine interface (BMI) that allows primates to use only their thoughts to navigate a robotic wheelchair. The BMI uses signals from hundreds of neurons recorded simultaneously in 2 regions of the monkeys’ brains that are involved in movement and sensation...

Read More

Achilles’ Heel of aggressive leukemia affecting children and adults found + new Rx

Their study focuses on a type of acute lymphoblastic leukemia (ALL) that involves a gene called TAL-1. Dr. Marjorie Brand and her team discovered that GSK-J4 can kill this form of cancer. By transplanting cancer cells from human patients into normal mice, the authors showed that the compound can kill the leukemia quickly, efficiently, and with no short-term side effects. GSK-J4 was created by the pharmaceutical industry for research purposes, and has never been used as a cancer therapy.

“It’s very exciting because this is the first time anyone has found a potential personalized treatment for this aggressive disease,” said Dr. Brand, a senior scientist at The Ottawa Hospital and professor at the University of Ottawa...

Read More